You asked us to provide more face-to-face events in 2025 and we're pleased to have to have facilitated this. Here's a look at our events in 2025. Find out more and book onto your nearest event. Read more
Today we're delighted to announce that Celebrated Bollywood and Netflix star Manisha Koirala is to become an Ambassador for Ovacome, starting from January 2025. Read more
The charity and group have won the Inspiring Collaboration award in recognition of their patient experience research which has improved ovarian cancer guidance Read more
Set to launch on Tuesday 12 November, this group offers our members based in Scotland the chance for regular online meetups every other month. Read more
Diagnosed with stage 4 ovarian cancer over a decade ago, celebrated Bollywood and Netflix star Manisha Koirala met with Ovacome staff and members. Read more
MEK-inhibitor trametinib has been supported for use in patients in Scotland with low grade serous ovarian carcinoma after at least one line of platinum-based chemotherapy. Read more
The trial treated patients with a combination of avutometinib and defactinib. 31% of participants saw their tumours shrink or stop growing. Read more
This weekend we’re in Bristol at We the Curious with Dr Elizabeth Dolan, Researcher at N/LAB at the University of Nottingham who’s PhD research looks at the use of shopping data, including loyalty card data, to see if women’s shopping habits can be connected to, or even predict an ovarian cancer diagnosis. Read more
Earlier this year, Ovacome’s Head of Support Services Anna Hudson worked alongside expert clinicians from the British Gynaecological Cancer Society (BGCS) and the British Menopause Society (BMS) to co-create the first, much-needed guidance on the management of menopausal symptoms following treatment of gynaecological cancer. Read more
We’re delighted to announce the appointment of Lady Sewell MBE as Ovacome’s newest Patron. Read more
A new clinical trial for patient in Wales tests the application of chemotherapy medicine via keyhole surgery to reach cancer tumours faster. Read more
Read more